These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 1706786

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients.
    Horoszewicz JS, Kawinski E, Murphy GP.
    Anticancer Res; 1987; 7(5B):927-35. PubMed ID: 2449118
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lewis Y antigen as detected by the monoclonal antibody BR96 is expressed strongly in prostatic adenocarcinoma.
    Myers RB, Srivastava S, Grizzle WE.
    J Urol; 1995 May; 153(5):1572-4. PubMed ID: 7714977
    [Abstract] [Full Text] [Related]

  • 11. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
    Starling JJ, Sieg SM, Beckett ML, Schellhammer PF, Ladaga LE, Wright GL.
    Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
    [Abstract] [Full Text] [Related]

  • 12. [Study of growth fraction on fine needle aspirated prostatic tissue smear using monoclonal antibody Ki-67].
    Sai S, Takashi M, Miyake K, Koshikawa T.
    Hinyokika Kiyo; 1991 Aug; 37(8):881-6. PubMed ID: 1957731
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Preliminary immunohistochemical characterization of a monoclonal antibody (PRO:4-216) prepared from human prostate cancer nuclear matrix proteins.
    Partin AW, Briggman JV, Subong EN, Szaro R, Oreper A, Wiesbrock S, Meyer J, Coffey DS, Epstein JI.
    Urology; 1997 Nov; 50(5):800-8. PubMed ID: 9372899
    [Abstract] [Full Text] [Related]

  • 15. Prostate cancer-associated markers.
    Chu TM.
    Immunol Ser; 1990 Nov; 53():339-56. PubMed ID: 1713065
    [Abstract] [Full Text] [Related]

  • 16. Antibody immunoglobulin G (IgG) against human prostatic specific antigen (PSA) as a carrier protein for chemotherapeutic drugs to human prostate tumors: Part 1. A double immunofluorescence analysis.
    Sinha AA, Sackrison JL, DeLeon OF, Wilson MJ, Gleason DF.
    Anat Rec; 1996 Aug; 245(4):652-61. PubMed ID: 8837723
    [Abstract] [Full Text] [Related]

  • 17. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma.
    Tamboli P, Amin MB, Schultz DS, Linden MD, Kubus J.
    Mod Pathol; 1996 Oct; 9(10):1015-9. PubMed ID: 8902840
    [Abstract] [Full Text] [Related]

  • 18. Immunohistochemical localization of human kallikreins 6, 10 and 13 in benign and malignant prostatic tissues.
    Petraki CD, Gregorakis AK, Papanastasiou PA, Karavana VN, Luo LY, Diamandis EP.
    Prostate Cancer Prostatic Dis; 2003 Oct; 6(3):223-7. PubMed ID: 12970725
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ki-67 antigen and P53 protein expression in benign and malignant prostatic lesions. Immunohistochemical quantitative study.
    Sasor A, Wagrowska-Danilewicz M, Danilewicz M.
    Pol J Pathol; 2000 Oct; 51(1):31-6. PubMed ID: 10833901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.